查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067705

臉部注射劑市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測（2026-2033 年）

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen And PMMA Microspheres, Hyaluronic Acid, Calcium Hydroxylapatite (CaHA), PLLA), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

臉部注射劑市場概覽

2025年全球臉部注射劑市場價值為118億美元，預計到2033年將達到221億美元，2026年至2033年的複合年成長率為8.2%。

近年來，消費者對外觀的日益關注推動了臉部填充劑需求的成長。

此外，市場主要參與企業透過各種美容宣傳活動提高人們對微創手術的認知度，也推動了市場的發展。根據美國臉部整形與重組外科學會 (AAFPRS) 於 2025 年 2 月發表的報導，脂肪移植手術的數量預計將增加 50%，凸顯了人們對臉部容量恢復日益成長的需求。此外，四分之一的外科醫生預計注射和皮膚緊緻等非手術治療的需求將會增加，預計市場將快速擴張。美容醫學的進步、不斷提高的美容標準以及人們對微創治療日益成長的偏好，都進一步促進了這一趨勢。

推動該市場成長的主要因素之一是全球美容手術數量的顯著增加。根據國際美容整形外科學會（ISAPS）預測，到2024年，全球將進行約3,800萬例美容手術，其中超過2,000萬例為非手術治療，包括注射類美容計畫。這比過去四年成長了42%，凸顯了微創治療方法的強勁趨勢。注射類美容計畫日益普及也得益於肉毒桿菌和皮膚填充劑注射數量的激增。同樣，根據美國整形外科醫師協會發表的數據，光是2024年就進行了超過530萬例玻尿酸填充劑注射，肉毒桿菌注射量也超過470萬例。此外，全球整體肉毒桿菌注射量已達約780萬例，使其成為最常見的非手術美容計畫。

另一個主要成長要素是微創手術在美容醫學領域的日益普及。根據美國臉部整形與重組外科學會預測，到2025年，非侵入性治療將佔所有美容手術的約80%，其中注射類產品（如填充劑和神經毒素）是推動這一領域成長的主要因素。這清楚地表明了業界對非手術​​治療方法的強烈偏好，並進一步推高了臉部注射產品的需求。

市場也受益於消費者人口結構的變化和意識的提高，尤其是在年輕一代。根據北美社區中心統計機構（Community Hub Statistics in North America）2025年12月發布的一項調查，到2025年，美國成年人口中將有3%至4%的人接受過某種形式的美容手術，其中大多數人會選擇非手術治療。這種早期接受和預防性美容護理的趨勢正在擴大消費者群體，並確保重複治療週期，這對市場的永續發展至關重要。

艾爾建（Allergan）、辛克萊製藥（Sinclair Pharma）和高德美（Galderma）等行業領導者的存在，預計將推動臉部填充劑治療的需求，並進而提升市場收入。這些企業提供全面的注射填充劑產品組合，可解決包括皺紋、色素沉著、豐唇、疤痕、臉部飽滿和臉部輪廓塑形在內的多種皮膚問題。此外，社群媒體曝光度的提高、臉部填充劑療效的增強和核准的完善，以及人們對美觀和年輕的日益成長的追求，預計都將在預測期內推動市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 臉部注射劑市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 臉部注射劑市場分析工具

第4章：臉部注射劑市場：產品具體估算與趨勢分析

  • 全球臉部注射劑市場：產品概覽
  • 全球臉部注射劑市場：基於產品的流體分析
  • 全球臉部注射劑市場估算與預測：按產品和銷售收入分類
  • 膠原蛋白和PMMA微球
  • 玻尿酸
    • 單相型
    • 雙相型
  • 羥磷石灰鈣（CaHA）
  • PLLA
  • PCL
  • PN/PDRN
  • 肉毒桿菌素（Botox）
  • 外泌體

第5章：臉部注射劑市場：按應用分類的估算和趨勢分析

  • 全球臉部注射劑市場：基於應用的儀表板
  • 全球臉部注射劑市場：基於應用的流體差異分析
  • 全球臉部注射劑市場估算與預測：按應用和銷售收入分類
  • 改善皺紋
  • 唇部豐盈度增加
  • 臉部輪廓
  • 疤痕治療
  • 容量損失修復
  • 其他

第6章：臉部注射劑市場：依最終用途分類的估算與趨勢分析

  • 全球臉部注射劑市場：按最終用途分類的概覽
  • 全球臉部注射劑市場：按最終用途分類的波動分析
  • 全球臉部注射劑市場估算與預測：按最終用途和銷售收入分類
  • 醫療美容中心
  • 整形外科中心
  • 醫院
  • 其他

第7章 臉部注射劑市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 新加坡
    • 馬來西亞
    • 台灣
    • 越南
    • 菲律賓
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司和競爭對手的分類
    • 主要公司市佔率分析（2025 年）
    • Ipsen
    • Abbvie
    • Medytox Inc.
    • Merz GmbH and Co. KGaA
    • Revance Therapeutics, Inc.
    • Galderma
    • Sinclair Pharma
Product Code: GVR-1-68038-849-7

Facial Injectable Market Summary

The global facial injectable market size was valued at USD 11.8 billion in 2025 and is projected to reach USD 22.1 billion by 2033, growing at a CAGR of 8.2% from 2026 to 2033. A growing focus on physical appearance among consumers has driven increased demand for facial injectables in recent years.

Increasing awareness regarding minimally invasive procedures due to various beauty campaigns being organized by key players in the market is also a driving factor for market growth. According to an article published by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2025, fat grafting procedures have increased by 50%, highlighting the growing emphasis on volume restoration. In addition, with one in four surgeons anticipating increased demand for non-surgical treatments, such as injectables and skin-tightening procedures, the market is set to expand rapidly. This trend is further fueled by advancements in aesthetic medicine, evolving beauty standards, and a rising preference for minimally invasive treatments.

One of the key drivers of this market is the significant rise in global aesthetic procedures. According to the International Society of Aesthetic Plastic Surgery, nearly 38 million aesthetic procedures were performed globally in 2024, with more than 20 million being non-surgical treatments, including injectables. This reflects a 42% increase over the past four years, highlighting the strong shift toward minimally invasive solutions. The growing popularity of injectables is further supported by high procedure volumes of botulinum toxin and dermal fillers. Similarly, the data published by the American Society of Plastic Surgeons shows that over 5.3 million hyaluronic acid filler procedures were performed in 2024 alone, while botulinum toxin procedures exceeded 4.7 million annually. Additionally, globally, botulinum toxin treatments reached approximately 7.8 million procedures, making them the most commonly performed non-surgical cosmetic treatment.

Another major growth factor is the dominance of minimally invasive procedures in aesthetic practice. According to the American Academy of Facial Plastic and Reconstructive Surgery, non-invasive treatments account for nearly 80% of all cosmetic procedures in 2025, with injectables such as fillers and neurotoxins leading this segment. This clearly indicates a strong industry preference for non-surgical solutions, further boosting the demand for facial injectables.

The market is also benefiting from changing consumer demographics and rising awareness, particularly among younger populations. According to the Study published by the North American Community Hub Statistics in December 2025 indicate that 3-4% of the adult population in the U.S. underwent some form of cosmetic procedure in 2025, with the majority opting for non-surgical treatments. This shift toward early adoption and preventive aesthetics is expanding the consumer base and ensuring repeat treatment cycles, which is critical for sustained market growth.

The presence of well-established key players such as Allergan, Sinclair Pharma, and Galderma with a comprehensive portfolio of injectable fillers treating a broad range of skin indications, such as wrinkles, pigmentation, plumping of lips, scars, restoring facial fullness, as well as enhancing facial contours, is expected to drive the demand for facial injectable procedures, thereby boosting market revenue. Increasing social media exposure, rising effectiveness, and approvals for facial injectables, as well as the escalating desire among the population to look aesthetically appealing and young, are expected to drive the market during the forecast period.

Global Facial Injectable Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global facial injectable market report based on product, application, end use and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Collagen and PMMA Microspheres
  • Hyaluronic Acid
    • Monophasic
    • Biphasic
  • Calcium Hydroxylapatite (CaHA)
  • PLLA
  • PCL
  • PN/PDRN
  • Botulinum Toxin (Botox)
  • Exosome
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Wrinkle Correction
  • Lip Augmentation
  • Facial Contouring
  • Scar Treatment
  • Volume Loss Restoration
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • MedSpas
  • Aesthetic Surgery Centers
  • Hospitals
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Vietnam
    • Philippines
    • Singapore
    • Malaysia
    • Taiwan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Facial Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing beauty consciousness among consumers
      • 3.2.1.2. Shift in consumer preference towards minimally invasive procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
  • 3.3. Facial Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Global Facial Injectable Market: Product Dashboard
  • 4.2. Global Facial Injectable Market: Product Movement Analysis
  • 4.3. Global Facial Injectable Market by Product, Revenue
  • 4.4. Collagen and PMMA Microspheres
    • 4.4.1. Collagen and PMMA Microspheres market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Hyaluronic Acid
    • 4.5.1. Hyaluronic Acid market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2. Monophasic
      • 4.5.2.1. Monophasic market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3. Biphasic
      • 4.5.3.1. Biphasic market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Calcium Hydroxylapatite (CaHA)
    • 4.6.1. Calcium Hydroxylapatite (CaHA) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. PLLA
    • 4.7.1. PLLA market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.8. PCL
    • 4.8.1. PCL market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.9. PN/PDRN
    • 4.9.1. PN/PDRN market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.10. Botulinum Toxin (Botox)
    • 4.10.1. Botulinum Toxin (Botox) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.11. Exosome
    • 4.11.1. Exosome market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Global Facial Injectable Market: Application Dashboard
  • 5.2. Global Facial Injectable Market: Application Movement Analysis
  • 5.3. Global Facial Injectable Market Estimates and Forecasts, By Application, Revenue (USD Million)
  • 5.4. Wrinkle Correction
    • 5.4.1. Wrinkle Correction market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Lip Augmentation
    • 5.5.1. Lip Augmentation market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Facial Contouring
    • 5.6.1. Facial Contouring market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Scar Treatment
    • 5.7.1. Scar Treatment market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Volume Loss Restoration
    • 5.8.1. Volume Loss Restoration market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Facial Injectable Market: End Use Estimates & Trend Analysis

  • 6.1. Global Facial Injectable Market: End use Dashboard
  • 6.2. Global Facial Injectable Market: End use Movement Analysis
  • 6.3. Global Facial Injectable Market Estimates and Forecasts, by End use, Revenue (USD Million)
  • 6.4. MedSpa
    • 6.4.1. MedSpa market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Aesthetic Surgery Centers
    • 6.5.1. Aesthetic Surgery Centers market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis by Product, Application, and End use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.9. Russia
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Russia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Singapore
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Malaysia
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework/ reimbursement structure
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.9. Taiwan
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework/ reimbursement structure
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Taiwan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.10. Vietnam
      • 7.5.10.1. Key country dynamics
      • 7.5.10.2. Regulatory framework/ reimbursement structure
      • 7.5.10.3. Competitive scenario
      • 7.5.10.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.11. Philippines
      • 7.5.11.1. Key country dynamics
      • 7.5.11.2. Regulatory framework/ reimbursement structure
      • 7.5.11.3. Competitive scenario
      • 7.5.11.4. Philippines market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
    • 8.1.1. Key company market share analysis, 2025
    • 8.1.2. Ipsen
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial performance
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. Abbvie
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial performance
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Medytox Inc.
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial performance
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Merz GmbH and Co. KGaA
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial performance
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Revance Therapeutics, Inc.
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial performance
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Galderma
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial performance
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Sinclair Pharma
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial performance
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Facial Injectable Market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S. Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Europe Facial Injectable Market, by region, 2021 - 2033 (USD Million)
  • Table 13 Europe Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 14 Europe Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 15 Europe Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Germany Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 17 Germany Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 18 Germany Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 19 UK Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 20 UK Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 21 UK Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 22 France Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 23 France Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 24 France Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Italy Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 26 Italy Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 27 Italy Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Spain Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 29 Spain Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 30 Spain Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 31 Denmark Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 32 Denmark Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 33 Denmark Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Sweden Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 35 Sweden Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 36 Sweden Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Norway Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 38 Norway Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 39 Norway Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Russia Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 41 Russia Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 42 Russia Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific Facial Injectable Market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 47 China Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 48 China Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 49 China Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Japan Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 51 Japan Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 52 Japan Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 53 India Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 54 India Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 55 India Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 57 South Korea Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 58 South Korea Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Australia Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 60 Australia Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Thailand Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 63 Thailand Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 64 Thailand Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Singapore Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 66 Singapore Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 67 Singapore Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 68 Malaysia Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 69 Malaysia Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 70 Malaysia Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Taiwan Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 72 Taiwan Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 73 Taiwan Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Vietnam Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 75 Vietnam Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 76 Vietnam Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Philippines Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 78 Philippines Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 79 Philippines Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 80 Latin America Facial Injectable Market, by region, 2021 - 2033 (USD Million)
  • Table 81 Latin America Facial Injectable Market, by product2021 - 2033 (USD Million)
  • Table 82 Latin America Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 83 Latin America Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 84 Brazil Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 85 Brazil Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 86 Brazil Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Mexico Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 88 Mexico Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 89 Mexico Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Argentina Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 91 Argentina Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 92 Argentina Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 93 MEA Facial Injectable Market, by region, 2021 - 2033 (USD Million)
  • Table 94 MEA Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 95 MEA Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 96 MEA Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 97 South Africa Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 98 South Africa Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 99 South Africa Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 100 Saudi Arabia Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 101 Saudi Arabia Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 102 Saudi Arabia Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 103 UAE Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 104 UAE Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 105 UAE Facial Injectable Market, by end use, 2021 - 2033 (USD Million)
  • Table 106 Kuwait Facial Injectable Market, by product, 2021 - 2033 (USD Million)
  • Table 107 Kuwait Facial Injectable Market, by application, 2021 - 2033 (USD Million)
  • Table 108 Kuwait Facial Injectable Market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Facial Injectable Market: market outlook
  • Fig. 9 Facial injectables competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Facial Injectable Market driver impact
  • Fig. 13 Facial Injectable Market restraint impact
  • Fig. 14 Facial Injectable Market: Product movement analysis
  • Fig. 15 Facial Injectable Market: Product outlook and key takeaways
  • Fig. 16 Collagen & PMMA microspheres market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Hyaluronic Acid market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Monophasic market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Biphasic market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Calcium Hydroxylapatite (CaHA) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 PLLA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 PCL market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 PN/PDRN market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Botulinum Toxin (Botox) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Exosome market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Facial Injectable Market: Application movement analysis
  • Fig. 27 Facial Injectable Market: Application outlook and key takeaways
  • Fig. 28 Wrinkle Correction market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Lip augmentation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Facial Contouring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Scar treatment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Volume Loss Restoration market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Facial Injectable Market: End use movement analysis
  • Fig. 35 Facial Injectable Market: End use outlook and key takeaways
  • Fig. 36 MedSpa market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Aesthetic Surgery Centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Global Facial Injectable Market: Regional movement analysis
  • Fig. 41 Global Facial Injectable Market: Regional outlook and key takeaways
  • Fig. 42 Global Facial Injectable Market share and leading players
  • Fig. 43 North America, by country
  • Fig. 44 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. key country dynamics
  • Fig. 46 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Canada key country dynamics
  • Fig. 48 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 UK key country dynamics
  • Fig. 51 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Germany key country dynamics
  • Fig. 53 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 France key country dynamics
  • Fig. 55 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Italy key country dynamics
  • Fig. 57 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Spain key country dynamics
  • Fig. 59 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Denmark key country dynamics
  • Fig. 61 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Sweden key country dynamics
  • Fig. 63 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Russia key country dynamics
  • Fig. 65 Russia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Norway key country dynamics
  • Fig. 67 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 China key country dynamics
  • Fig. 70 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Japan key country dynamics
  • Fig. 72 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 India key country dynamics
  • Fig. 74 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Thailand key country dynamics
  • Fig. 76 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 South Korea key country dynamics
  • Fig. 78 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Australia key country dynamics
  • Fig. 80 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Singapore key country dynamics
  • Fig. 82 Singapore market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Malaysia key country dynamics
  • Fig. 84 Malaysia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Taiwan key country dynamics
  • Fig. 86 Taiwan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Vietnam key country dynamics
  • Fig. 88 Vietnam market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Philippines key country dynamics
  • Fig. 90 Philippines market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Brazil key country dynamics
  • Fig. 93 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Mexico key country dynamics
  • Fig. 95 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Argentina key country dynamics
  • Fig. 97 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 South Africa key country dynamics
  • Fig. 100 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Saudi Arabia key country dynamics
  • Fig. 102 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 UAE key country dynamics
  • Fig. 104 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Kuwait key country dynamics
  • Fig. 106 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 107 Market share of key market players- Facial Injectable Market